Quadrature Capital Ltd Purchases 475,725 Shares of Oscar Health, Inc. $OSCR

Quadrature Capital Ltd boosted its holdings in Oscar Health, Inc. (NYSE:OSCR) by 1,973.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 499,829 shares of the company’s stock after acquiring an additional 475,725 shares during the quarter. Quadrature Capital Ltd owned 0.20% of Oscar Health worth $10,724,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Thrive Capital Management LLC raised its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. CWM LLC boosted its position in shares of Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company’s stock valued at $42,000 after buying an additional 1,078 shares during the last quarter. XTX Topco Ltd bought a new stake in Oscar Health in the 1st quarter worth about $613,000. BIT Capital GmbH raised its position in Oscar Health by 1.1% in the 1st quarter. BIT Capital GmbH now owns 4,521,445 shares of the company’s stock worth $59,276,000 after buying an additional 47,592 shares during the last quarter. Finally, Wealthspire Advisors LLC purchased a new position in Oscar Health in the 1st quarter worth about $137,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of the stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the sale, the insider owned 501,148 shares in the company, valued at approximately $9,236,157.64. This represents a 44.08% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on OSCR shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a report on Wednesday, October 8th. Piper Sandler upgraded shares of Oscar Health from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $13.00 to $25.00 in a research report on Tuesday. UBS Group lifted their target price on shares of Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a research report on Friday, November 7th. Zacks Research upgraded shares of Oscar Health from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. Finally, Barclays increased their price target on Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a report on Monday, November 10th. One analyst has rated the stock with a Buy rating, five have issued a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Oscar Health has an average rating of “Reduce” and an average price target of $14.86.

Oscar Health Trading Down 1.3%

Oscar Health stock opened at $17.92 on Friday. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.80. The firm has a market capitalization of $4.74 billion, a price-to-earnings ratio of -16.00 and a beta of 1.88. The firm has a 50 day moving average of $18.16 and a 200 day moving average of $16.93. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.02. The business had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The company’s revenue for the quarter was up 23.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.22) earnings per share. Oscar Health has set its FY 2025 guidance at EPS. As a group, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.